Pembrolizumab in EU

This topic is empty.

Post

- July 1, 2014 at 5:53 pm
- Quote
RJoeyB
Participant
Merck announced yesterday that pembro has officially been accepted into and started the approval process in the EU by their regulating body:

Merck’s Investigational Anti-PD-1 Antibody, Pembrolizumab, Under Regulatory Review in Europe for the Treatment of Advanced Melanoma – MarketWatch

http://www.marketwatch.com/story/mercks-investigational-anti-pd-1-antibody-pembrolizumab-under-regulatory-review-in-europe-for-the-treatment-of-advanced-melanoma-2014-06-30

You must be logged in to reply to this topic.

The MRF Patient Forum is the oldest and largest online community of people affected by melanoma. It is designed to provide peer support and information to caregivers, patients, family and friends. There is no better place to discuss different parts of your journey with this cancer and find the friends and support resources to make that journey more bearable.

The information on the forum is open and accessible to everyone. To add a new topic or to post a reply, you must be a registered user. Please note that you will be able to post both topics and replies anonymously even though you are logged in. All posts must abide by MRF posting policies.